Towards Healthcare
Plant-Based Excipients Market
Updated Date: 30 January 2026   |   Report Code: 6638

Plant-Based Excipients Market Size and Companies (2026-2035)

According to our insight calculates, the plant-based excipients market was valued at USD 2.09 billion in 2025 and is expected to reach USD 2.18 billion in 2026, growing steadily to USD 3.19 billion by 2035 at a CAGR of 4.32% from 2026 to 2035.

Last Updated : 30 January 2026 Category: Pharmaceuticals Insight Code: 6638 Format: PDF / PPT / Excel

Content

1. Executive Summary

  • 1.1. Market Overview
    • 1.1.1. Definition of the Plant-Based Excipients Market
    • 1.1.2. Key Market Trends & Drivers
    • 1.1.3. Market Size and Forecast (2025–2034)
  • 1.2. Key Insights
    • 1.2.1. Growth Rate and Market Value Estimates
    • 1.2.2. Key Opportunities
    • 1.2.3. Key Risks and Challenges

2. Market Overview

  • 2.1. Market Dynamics
    • 2.1.1. Market Drivers
    • 2.1.2. Market Restraints
    • 2.1.3. Market Opportunities
    • 2.1.4. Technological Advancements and Impact
    • 2.1.5. Regulatory Environment and Its Effect on the Market
  • 2.2. Market Structure and Analysis
    • 2.2.1. Market Segmentation Overview
    • 2.2.2. Market Competition and Competitive Landscape
  • 2.3. Value Chain Analysis
    • 2.3.1. Value Chain Impact on Chemical Nature and Applications
    • 2.3.2. Sourcing and Sustainability Factors
    • 2.3.3. Role of Plant-Based Excipients in Drug Development and Formulation

3. Segmentation Analysis

  • 3.1. By Chemical Nature
    • 3.1.1. Carbohydrates
      • 3.1.1.1. Market Size and Forecast
      • 3.1.1.2. Role in Pharmaceutical Formulation
      • 3.1.1.3. Key Applications and Trends
    • 3.1.2. Proteins
      • 3.1.2.1. Market Growth and Adoption
      • 3.1.2.2. Functional Benefits in Drug Formulation
    • 3.1.3. Polymers
      • 3.1.3.1. Market Insights and Growth Trends
      • 3.1.3.2. Key Applications and Market Dynamics
    • 3.1.4. Minerals
      • 3.1.4.1. Market Trends and Forecast
      • 3.1.4.2. Functional Uses and Innovation
    • 3.1.5. Glycosides & Waxes
      • 3.1.5.1. Market Growth and Adoption Rates
      • 3.1.5.2. Functional Benefits in Pharmaceuticals
    • 3.1.6. Esters
      • 3.1.6.1. Market Dynamics and Forecast
      • 3.1.6.2. Key Trends and Applications in Drug Formulation
    • 3.1.7. Ethers & Carboxylic Acids
      • 3.1.7.1. Market Trends and Forecast
      • 3.1.7.2. Applications in Drug Development
    • 3.1.8. Others
      • 3.1.8.1. Emerging Excipients and Market Forecast
      • 3.1.8.2. Novel Plant-Based Excipients in Drug Formulation
  • 3.2. By Applications and Function
    • 3.2.1. Binders & Diluents
      • 3.2.1.1. Market Size and Forecast
      • 3.2.1.2. Functional Benefits in Drug Formulation
    • 3.2.2. Glidants
      • 3.2.2.1. Market Trends and Forecast
      • 3.2.2.2. Applications in Pharmaceutical Production
    • 3.2.3. Lubricants & Disintegrants
      • 3.2.3.1. Market Growth and Adoption Trends
      • 3.2.3.2. Role in Tablet Formulation and Performance
    • 3.2.4. Film Forming & Coating Agents
      • 3.2.4.1. Market Size and Adoption Trends
      • 3.2.4.2. Functional Uses in Drug Development
    • 3.2.5. Plasticizers
      • 3.2.5.1. Market Forecast and Adoption Rates
      • 3.2.5.2. Role in Drug Delivery Systems
    • 3.2.6. Suspended Agents
      • 3.2.6.1. Market Trends and Forecast
      • 3.2.6.2. Functional Roles in Pharmaceutical Products
    • 3.2.7. Preservatives & Antioxidants
      • 3.2.7.1. Market Insights and Trends
      • 3.2.7.2. Applications in Pharmaceutical Formulations
    • 3.2.8. Colorants & Flavoring Agents
      • 3.2.8.1. Market Growth and Adoption
      • 3.2.8.2. Functional and Aesthetic Benefits
  • 3.3. By Region
    • 3.3.1. North America
      • 3.3.1.1. Market Size & Trends (U.S., Canada, Mexico)
      • 3.3.1.2. Adoption Insights and Regional Trends
    • 3.3.2. Europe
      • 3.3.2.1. Market Dynamics and Trends (UK, Germany, France, etc.)
      • 3.3.2.2. Regional Adoption Insights and Growth Drivers
    • 3.3.3. Asia Pacific
      • 3.3.3.1. Market Forecast (Japan, China, India, etc.)
      • 3.3.3.2. Regional Dynamics and Technological Advancements
    • 3.3.4. Latin America
      • 3.3.4.1. Market Insights and Growth Potential (Brazil, Argentina, etc.)
      • 3.3.4.2. Market Drivers and Barriers
    • 3.3.5. Middle East & Africa
      • 3.3.5.1. Market Trends & Forecast (South Africa, Saudi Arabia, UAE)
      • 3.3.5.2. Regional Adoption Trends and Competitive Landscape

4. Cross-Segment Analysis

  • 4.1. Chemical Nature x Applications & Functions
    • 4.1.1. Market Correlations and Growth Insights
    • 4.1.2. Key Cross-Segment Drivers and Challenges
  • 4.2. Applications x Region x End-User
    • 4.2.1. Regional Insights for Key Application Growth
    • 4.2.2. End-User Segment Analysis by Region
  • 4.3. Competitive Landscape across Segments
    • 4.3.1. Company Positioning in Chemical Nature and Applications
    • 4.3.2. Market Share Analysis by Region and Application

5. Competitive Landscape

  • 5.1. Company Profiling
    • 5.1.1. Roquette Frères
    • 5.1.2. BASF Corporation (BASF SE)
    • 5.1.3. Lonza Group AG
    • 5.1.4. DFE Pharma
    • 5.1.5. Evonik Industries AG
    • 5.1.6. Micro Powders, Inc.
  • 5.2. Market Share Analysis
  • 5.3. Strategic Initiatives and Competitive Strategies
  • 5.4. Recent Developments and Key Innovations

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. Market Trends and Growth Drivers
    • 6.1.2. Adoption Insights and Regulatory Landscape
  • 6.2. Europe
    • 6.2.1. Market Dynamics and Growth Potential
    • 6.2.2. Adoption Insights and Regulatory Impacts
  • 6.3. Asia Pacific
    • 6.3.1. Emerging Trends and Opportunities
    • 6.3.2. Technological Developments in the Region
  • 6.4. Latin America
    • 6.4.1. Market Insights and Growth Factors
    • 6.4.2. Competitive Landscape
  • 6.5. Middle East & Africa
    • 6.5.1. Market Dynamics and Growth Forecast
    • 6.5.2. Adoption Trends and Challenges

7. Strategic Insights

  • 7.1. Key Growth Strategies
    • 7.1.1. Market Entry and Expansion Strategies
    • 7.1.2. Product Development and Innovation Insights
  • 7.2. Risk Analysis
    • 7.2.1. Key Risks in Market Growth
    • 7.2.2. Mitigation Strategies
  • 7.3. Opportunities in the Market
    • 7.3.1. New Market Entrants and Innovations
    • 7.3.2. Investment and Acquisition Trends

8. Technology and Regulatory Analysis

  • 8.1. Technological Trends Impacting the Plant-Based Excipients Market
    • 8.1.1. Innovations in Excipients Derived from Plant Sources
    • 8.1.2. Role of Plant-Based Excipients in Sustainable Formulations
  • 8.2. Regulatory Environment
    • 8.2.1. Regulatory Approvals and Compliance in Different Regions
    • 8.2.2. Impact of FDA and EMA Regulations on Plant-Based Excipients
  • 8.3. Pricing Analysis
    • 8.3.1. Pricing Trends and Strategies for Key Excipients
    • 8.3.2. Factors Influencing Pricing in Plant-Based Excipients

9. Market Forecast

  • 9.1. Market Size and Forecast (2025–2034)
    • 9.1.1. Global Market Size and Growth Rate
    • 9.1.2. Market Size by Segment (Chemical Nature, Application, Region, etc.)
    • 9.1.3. Market Share Analysis by Key Companies
  • 9.2. Regional Market Forecast
    • 9.2.1. North America Forecast
    • 9.2.2. Europe Forecast
    • 9.2.3. Asia Pacific Forecast
    • 9.2.4. Latin America Forecast
    • 9.2.5. Middle East & Africa Forecast
  • 9.3. Segment-wise Growth Projections
    • 9.3.1. Chemical Nature Segment Forecasts
    • 9.3.2. Applications and Function Forecasts
    • 9.3.3. End-User Segment Forecasts

10. Strategic Recommendations

  • 10.1. Recommendations for Manufacturers and Suppliers
    • 10.1.1. Investment and Product Development Strategies
    • 10.1.2. Technological Advancements and Integrations
  • 10.2. Recommendations for Investors
    • 10.2.1. High-Growth Segments for Investment
    • 10.2.2. Regional Investment Opportunities
  • 10.3. Recommendations for Policymakers
    • 10.3.1. Regulatory Frameworks and Support for Innovation
    • 10.3.2. Healthcare Accessibility and Adoption Incentives

11. Conclusion

  • 11.1. Summary of Key Findings
    • 11.1.1. Market Growth Trends
    • 11.1.2. Competitive Landscape Insights
    • 11.1.3. Key Technological Developments
  • 11.2. Final Thoughts on Market Opportunities and Risks
    • 11.2.1. Key Opportunities for Stakeholders
    • 11.2.2. Key Risks and Mitigation Strategies

12. Appendix

  • 12.1. Glossary of Terms
  • 12.2. Research Methodology
  • 12.3. List of Figures and Tables
  • 12.4. Additional Resources and References
  • 12.5. Company Profiles of Key Market Players

FAQ's

Answer : The plant-based excipients market is on a steady growth path rising from USD 2.18 billion in 2026 to about USD 3.19 billion by 2035, growing at a 4.32% CAGR.

Answer : North America is currently leading the plant-based excipients market due to strong pharmaceutical and nutraceutical industries, high consumer awareness of natural and clean-label products

Answer : Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.  

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar